Interstitial Lung Disease Clinical Trials

Find Interstitial Lung Disease Clinical Trials Near You

Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease - an Observational Study

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this observational study is to evaluate the feasibility and acceptability of a newly developed digital education and self-management program for people with fibrotic interstitial lung diseases (FILD) during inpatient pulmonary rehabilitation and outpatient interstitial lung disease (ILD) care. The study also explores whether participation in the program is associated with changes in health-related outcomes. The main questions this study aims to answer are: * Is the digital education and self-management program acceptable, useful, and practical for patients with FILD? * Is it feasible to recruit and retain patients and to collect outcome data for a future larger effectiveness study? * Do patients who participate in the program show differences in health-related outcomes compared with patients treated before the program was implemented? Patients who consent to participate during the implementation phase will be offered access to the digital education and self-management program. Their outcomes will be compared with those of a historical cohort of patients who received usual care before the program was introduced. Participants will: * Use a web-based digital education and self-management program with multiple e-learning modules tailored to individual needs and preferences * Access the program via smartphone, tablet, or computer during inpatient rehabilitation or outpatient care * Discuss questions related to the program content with healthcare professionals during routine rehabilitation sessions or clinic visits * Complete questionnaires about their experience with the program and their health-related outcomes

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Diagnosis of a FILD as major indication for pulmonary rehabilitation (for Berner Reha Zentrum only)

• Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB\_2016-01524) and agreed to further use of data for further research purpose (for Inselspital only)

• Age ≥ 18 years

• Written informed consent

Locations
Other Locations
Switzerland
Department for Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
NOT_YET_RECRUITING
Bern
Center for Rehabilitation & Sports Medicine Inselspital and Berner Reha Zentrum, Bern University Hospital, University of Bern, Switzerland
RECRUITING
Heiligenschwendi
Contact Information
Primary
Thimo Marcin, PhD
thimo.marcin@rehabern.ch
+41 33 244 3048
Backup
Thomas Franz Riegler, PhD
thomas.riegler@zhaw.ch
+41 (0) 58 934 64 06
Time Frame
Start Date: 2025-10-07
Estimated Completion Date: 2027-08
Participants
Target number of participants: 80
Treatments
Experimental: Intervention group
This arm includes patients with fibrotic interstitial lung diseases enrolled in the observational study during the feasibility phase. Participants who consent to participate are offered access to a blended digital education and self-management program in addition to usual inpatient pulmonary rehabilitation or outpatient ILD care.
Sponsors
Collaborators: ZHAW School of Health Professions, Institute of Physiotherapy, University of Zurich
Leads: Insel Gruppe AG, University Hospital Bern

This content was sourced from clinicaltrials.gov